Global market for treatments for syndromes of dementia & movement disorders to grow to $16.7 bn. in 2017

October 4, 2012

The global market for treatments for syndromes of dementia and movement disorders was valued at $10.5 billion in 2011 and should reach $11.1 billion in 2012. Total market value is expected to reach $16.7 billion in 2017 increasing at a five-year compound annual growth rate (CAGR) of 8.5%.

Learn about the present and future strategies within the neurodegenerative disorder market, which includes treatments and therapies for progressive dementia, progressive dementia with other neurological abnormalities and movement disorders. Market gains, setbacks, the regulatory environment, new developments and company profiles are also discussed in this report…

Use this report to:

  • Gain an overview of the current and future characteristics of the global markets for treatments for syndromes of dementia and movement disorders
  • Breakdown revenues by neurodegenerative disease and primary clinical/pathological feature
  • Review applications for treatments and therapeutic technologies for syndromes of dementia and movement disorders
  • Identify the major players in the industry most likely to compete well now and into the future
  • Review patent information relevant to the industry.

To provide further information about this report we offer a Complimentary Introduction, available from our Website. To download, simply click here, go to the Table of Contents tab, add the complimentary introduction to your cart, and confirm your order.

RSS Feeds – Pharmaceuticals

SUMMARY FIGURE
GLOBAL MARKET FOR TREATMENTS FOR SYNDROMES OF DEMENTIA AND MOVEMENT DISORDERS, 2010-2017
($ MILLIONS)

Source: BCC Research

Global mental health pharmaceutical industry to reach $88.3bn by 2015

September 11, 2012

The global mental health pharmaceutical industry was estimated at $80.5 billion in 2010. By 2015, this market is likely to reach $88.3 billion, at a compound annual growth rate (CAGR) of 1.9% from 2010 to 2015.

Learn about the current state of pharmaceutical markets, and new drug development in the mental health segment, existing products on the market, and a detailed analysis of the competitive environments, including new potential markets and trends…


Use this report to:

  • Gain a comprehensive view of the current state of the pharmaceutical marketplace, and new drug developments in the mental health segment
  • Identify and evaluate new markets, trends, and developments in the mental health pharmaceutical industry, including potential new geographic markets and emerging products such as memory enhancement drugs
  • Asses the competitive environment, the status and strategies of major market participants, and whether your company is appropriately positioned to capture market share
  • Understand the drivers and challenges that affect growth and development in each submarket or category of psychiatric drugs.

To provide further information about this report we offer a Complimentary Introduction, available from our Website. To download, simply click here, go to the Table of Contents tab, add the complimentary introduction to your cart, and confirm your order.

RSS Feeds – Pharmaceuticals

GLOBAL MENTAL HEALTH PHARMACEUTICAL INDUSTRY BY DRUG CATEGORY, 2009-2015

($ BILLIONS)


Global market for pharma contract manufacturing & research to grow to $360.6 billion by 2016

September 6, 2012

The global market for pharmaceutical contract manufacturing, research and packaging was at $196.5 billion in 2010 and will further grow to $217.9 billion in 2011. It is projected to reach $360.6 billion by 2016, increasing at a compound annual growth rate (CAGR) of 10.6%.

Learn about the current situation and future capabilities of the global pharmaceutical contract manufacturing, research, and packaging markets and about the trends for global as well as regional markets. Company profiles and patent analysis are provided as well…

Use this report to:

  • Determine the current and future outlook of the pharmaceutical contract manufacturing market, with a comprehensive analysis of the overall pharmaceutical and biotechnology outsourcing industry
  • Identify different types of contract manufacturing and, more specifically, the services offered by global contract manufacturers, researchers, and packagers
  • Understand market forecasts for different aspects of contract manufacturing specific to each region, and examine the role of market leaders in the industry
  • Learn about patents, regulatory requirements and new developments in the market.

To provide further information about this report we offer a Complimentary Introduction, available from our Website. To download, simply click here, go to the Table of Contents tab, add the complimentary introduction to your cart, and confirm your order.

RSS Feeds – Pharmaceuticals

GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING AND CONTRACT RESEARCH ORGANIZATIONS REVENUE, 2009-2016

($ BILLIONS)


Global market for antifungal therapeutics to grow to $12.2 billion in 2016

August 16, 2012

The global market for antifungal therapeutics was valued at $10.7 billion in 2011 and is projected to reach $12.2 billion in 2016, a five-year compound annual growth rate (CAGR) of 2.7%.

Learn about applications, both marketed and in development, for antifungal technologies. In an extensive analysis, BCC examines each market segment, presents its current market status, and presents various forecasts for growth over the next five years. Company profiles and patent analysis are also included in this report…

Use this report to:

  • Determine the current status of the global human antifungal market and assess the market’s growth potential over the five-year period from 2011 to 2016
  • Identify new antifungal research, development, new drug applications, and novel approaches to the market
  • Analyze data regarding the market shift for those products that are now relegated to over-the-counter (OTC) status, products which previously required a prescription
  • Receive information on industry structure including market shares and also receive patent analysis of the industry.

To provide further information about this report we offer a Complimentary Introduction, available from our Website. To download, simply click here, go to the Table of Contents tab, add the complimentary introduction to your cart, and confirm your order.

RSS Feeds – Pharmaceuticals

GLOBAL SALES OF HUMAN ANTIFUNGALS, 2011 AND 2016

($ MILLIONS)